Sequence Similarity Clusters for the Entities in PDB 1MCQ

Entity #1 | Chains: A,B
IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 15 19 1359
95 % 15 20 1552 Flexibility: Medium
Max RMSD: 14.5, Avg RMSD: 7.2
PDBFlex
90 % 55 86 257
70 % 1587 2670 1
50 % 3241 5421 1
40 % 3687 6121 1
30 % 4523 7588 1
Entity #2 | Chains: P
PEPTIDE N-ACETYL-L-HIS-D-PRO-NH2 protein, length: 4 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 5IVN 1 A BC2-nanobody 30538
3 5E7B 1 A nanobody nano-L06 9838
4 2P45 2 B ANTIBODY CAB-RN05 9838
5 2X1Q 1 A, B GELSOLIN NANOBODY 9844
6 5U64 1 B VHH-28 9838
7 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
8 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
9 4B41 1 A, B ANTIBODY G7 9844
10 4NZU 1 L 13PL heavy chain Fab 9606
11 4NZU 2 H 13PL light chain Fab 9606
12 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
13 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
14 5IMM 1 B Nanobody 9835
15 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
16 5NLU 1 A single domain llama antibody Nb36 9844
17 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
19 1MEX 1 L Fab 29G12 light chain 10090
20 1MEX 2 H Fab 29G12 heavy chain 10090
21 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
22 5IMK 1 B Nanobody 9835
23 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
25 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
26 4BUH 1 A, B CLONE M0418 SCFV 9606
27 4B50 1 A 2H10 LLAMA VHH 9844
28 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
29 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
30 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
31 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
32 6DBA 1 A, B nanobody VHH R303 9838
33 5YD4 1 A, C, E, G scFv 4B08 10090
34 5YD3 1 A, C, E, G scFv 4B08 10090
35 2XT1 2 B CAMELID VHH 9 30538
36 5UD9 1 H Fab heavy chain 9606
37 5UD9 2 L Light chain 9606
38 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
39 4P48 1 A Antibody scFv 180 9031
40 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
41 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
42 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
43 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
44 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
45 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
46 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
47 5J1S 3 C VHH domain BS-2 30538
48 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
49 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
50 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
51 6BJZ 1 H 5c8 Fab Heavy chain 9606
52 6BJZ 2 L 5c8 Fab Light chain 9606
53 5J1T 3 C VHH domain BS-2 30538
54 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
55 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
56 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
57 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
58 4XCF 1 L 4E10 Fab light chain 9606
59 4XCF 2 H 4E10 Fab heavy chain 9606
60 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
61 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
62 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
63 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
64 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
65 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
66 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
67 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
68 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
69 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
70 5X08 1 H Fab 4E10 Heavy chain 9606
71 5X08 2 L Fab 4E10 Light chain 9606
72 2X1O 1 A, B GELSOLIN NANOBODY 9844
73 4QGY 1 A, B nanobody n25, VH domain 9844
74 5C2B 1 H scFv 3B4 heavy chain 9606
75 4XAW 1 L 4E10 Fab light chain 9606
76 4XAW 2 H 4E10 Fab heavy chain 9606
77 5VNV 1 A Nb.b201 32630
78 4P49 1 A Antibody scFv B8 9031
79 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
80 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
81 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
82 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
83 5DXW 1 A PD-L1 nanobody 10090
84 5UCB 1 H Fab Heavy Chain 9606
85 5UCB 2 L Fab Light Chain 9606
86 2VXV 1 H HUMAN IGG ABT-325 9606
87 2VXV 2 L HUMAN IGG ABT-325 9606
88 4N9O 2 B Nanobody Nb484 Nb484 9844
89 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
90 4GXV 1 H, I Antibody 1F1, heavy chain 9606
91 4GXV 2 L, M Antibody 1F1, light chain 9606
92 2VXT 1 H MURINE IGG 125-2H 10090
93 2VXT 3 L MURINE IGG 125-2H 10090
94 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
95 1T2J 1 A M12-Variable Heavy domain 9606
96 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
97 6DBF 2 B InlB specific VHH R303 9838
98 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
99 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
100 6DBG 2 C, D VHH R303 9838
101 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
102 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
103 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
104 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
105 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
106 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
107 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
108 5W24 1 L 5C4 Fab Light Chain 10090
109 5W24 2 H 5C4 Fab Heavy Chain 10090
110 4HPY 1 H CH59 Fab heavy chain 9606
111 4HPY 2 L CH59 Fab light chain 9606
112 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
113 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
114 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
115 5VM6 1 A single domain camelid nanobody VHH T10 9844
116 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
117 4JG1 1 L Fab light chain 9606
118 4JG1 2 H Fab heavy chain 9606
119 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
120 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
121 4KML 2 B Nanobody 9844
122 5VF2 1 A scFv 2D10 10090
123 5I8C 1 A VRC34.01 Fab heavy chain 9606
124 5I8C 2 B VRC34.01 Fab light chain 9606
125 4O5L 1 L Fab F045-092 light chain 9606
126 4O5L 2 H Fab F045-092 heavy chain 9606
127 5MYX 1 A, C Fab c#24 light chain 10090
128 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
129 4Z9K 2 B VHH2(F5) antibody 30538
130 3IFL 1 L 12A11 FAB antibody light chain 10090
131 3IFL 2 H 12A11 FAB antibody heavy chain 10090
132 5WK2 1 L M116 LIGHT CHAIN 9606
133 5WK2 2 H M116 HEAVY CHAIN FD 9606
134 3PP4 1 H GA101 Fab heavy chain 10090
135 3PP4 2 L GA101 Fab light chain 10090
136 3KDM 1 A, L Immunoglobulin light chain 9606
137 3KDM 2 B, H Immunoglobulin heavy chain 9606
138 5NIV 1 A Light chain of 5D3 Fab 10090
139 5NIV 2 B Heavy chain of 5D3 Fab 10090
140 5N4J 1 L LIGHT CHAIN 9606
141 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
142 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
143 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
144 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
145 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
146 5X4G 1 A 6H8 Fab heavy chain 10090
147 5X4G 2 B 6H8 Fab light chain 10090
148 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
149 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
150 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
151 4PTU 1 A Antibody pn132p2C05, light chain 9606
152 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
153 4TPR 1 L If kappa light chain 10090
154 4TPR 2 H Fab heavy chain 10090
155 5LMW 1 A Nanobody 9844
156 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
157 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
158 3IFN 1 H 12A11 FAB antibody heavy chain 10090
159 3IFN 2 L 12A11 FAB antibody light chain 10090
160 5U3P 1 H DH511.4 Fab Heavy Chain 9606
161 5U3P 2 L DH511.4 Fab Light Chain 9606
162 6BLA 1 H AMM01 Fab Heavy chain 9606
163 6BLA 2 L AMM01 Fab Light chain 9606
164 5NM0 1 A, B, C, D Nb36 9844
165 4TOY 1 H 35O22 Fab Heavy chain 9606
166 4TOY 2 L 35O22 Fab Light chain 9606
167 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
168 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
169 3NPS 2 B S4 FAB HEAVY CHAIN 9606
170 3NPS 3 C S4 FAB LIGHT CHAIN 9606
171 5I4F 1 A scFv 2D10 10090
172 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
173 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
174 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
175 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
176 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
177 5WN9 1 H scFv 2D10 9606
178 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
179 4XC3 1 L 4E10 Fab light chain 9606
180 4XC3 2 H 4E10 Fab heavy chain 9606
181 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
182 4PPT 1 A Engineered single domain VHH antibody 9844
183 3R0M 1 A, B Llama VHH A12 9844
184 4M5Y 1 H, I Fab 5J8 heavy chain 9606
185 4M5Y 2 L, M Fab 5J8 light chain 9606
186 4TQE 1 L If kappa light chain 10090
187 4TQE 2 H Fab heavy chain 10090
188 3ZKQ 2 D XA4813 9844
189 5YY4 1 A scFv 4B08 10090
190 4I13 2 B Protein ca1697 (nanobody) 9844
191 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
192 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
193 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
194 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
195 5C2U 1 B Nanobody Nanobody 9838
196 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
197 5VSI 2 L CH1/Ckappa Fab light chain 9606
198 1XFP 1 A heavy chain antibody VHH domain 9838
199 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
200 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
201 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
202 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
203 5JXA 1 H VRC03 Heavy chain 9606
204 5JXA 2 L VRC03 Light chain 9606
205 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
206 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
207 4POY 1 A VHH-metal 9844
208 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
209 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
210 5NLW 1 A nanobody Nb36 9844
211 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
212 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
213 3NTC 1 L Fab light chain 10090
214 3NTC 2 H Fab heavy chain 10090
215 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
216 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
217 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
218 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
219 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
220 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
221 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
222 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
223 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
224 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
225 6BE3 1 H Fab (F598) Heavy Chain 9606
226 6BE3 2 L Fab (F598) Light Chain 9606
227 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
228 3G9A 2 B Minimizer 9838
229 4NWU 1 H APE1551 Ab Fab heavy chain 9606
230 4NWU 2 L APE1551 Ab Fab light chain 9606
231 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
232 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
233 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
234 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
235 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
236 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
237 5EWI 1 H VRC38.01 Heavy Chain 9606
238 5EWI 2 L VRC38.01 Light Chain 9606
239 5E2W 1 L AT8 LIGHT CHAIN 10090
240 5E2W 2 H AT8 HEAVY CHAIN 10090
241 5MYK 1 A Fab c#17 light chain 10090
242 5MYK 2 B Fab c#17 heavy chain 10090
243 4NZR 1 H PGT135 heavy chain Fab 9606
244 4NZR 2 L PGT135 light chain Fab 9606
245 5MYO 1 A, C Fab c#6 light chain 10090
246 5MYO 2 B, D Fab c#6 heavy chain 10090
247 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
248 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
249 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
250 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
251 5UEL 1 H 354NC102 Fab Heavy Chain 9606
252 5UEL 2 L 354NC102 Fab Light Chain 9606
253 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
254 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
255 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
256 2P43 2 B ANTIBODY CAB-RN05 9838
257 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
258 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
259 5E2V 1 L AT8 LIGHT CHAIN 10090
260 5E2V 2 H AT8 HEAVY CHAIN 10090
261 4KRN 1 A Nanobody/VHH domain EgA1 9844
262 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
263 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
264 4GFT 2 B Nanobody 9844
265 4TVS 2 a, b VHH Domain BS-1 30538
266 4W6Y 2 B Nanobody NbFedF9 9844
267 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
268 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
269 6EZW 1 B VHH antibody BCD090-M2 9844
270 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
271 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
272 5JUE 1 L light chain of UIC2 Fab 10090
273 5JUE 2 H heavy chain of UIC2 Fab 10090
274 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
275 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
276 1UAC 2 H Ig VH,anti-lysozyme 10090
277 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
278 5JR1 1 H 10E8 heavy chain 9606
279 5JR1 2 L 10E8 mature light chain 9606
280 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
281 6CA7 1 L PCT64_13C light chain 9606
282 6CA7 2 H PCT64_13C heavy chain 9606
283 5VF6 1 A single chain variable fragment 9031
284 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
285 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
286 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
287 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
288 5OB5 2 H fAb Heavy chain 9606
289 5OB5 3 L fAb Light chain 9606
290 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
291 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
292 5I66 1 A 8B6 antibody, heavy chain 10090
293 5I66 2 B 8B6 antibody, light chain 10090
294 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
295 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
296 6BZY 1 H 22D11 Heavy Chain 10090
297 6BZY 2 L 22D11 Light Chain 10090
298 3QQ9 1 C, L 101F LIGHT CHAIN 10090
299 3QQ9 2 D, H 101F HEAVY CHAIN 10090
300 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
301 5TKK 3 L mouse antibody vFP5.01 light chain 10090
302 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
303 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
304 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
305 5W6C 1 H UCA Fab heavy chain 9606
306 5W6C 2 L UCA Fab light chain 9606
307 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
308 5I1K 1 L FAB LIGHT CHAIN 9606
309 5I1K 2 H FAB HEAVY CHAIN 9606
310 3OZ9 1 L Fab NC-1 kappa light chain 10090
311 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
312 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
313 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
314 5V7U 1 L CBTAU-22.1 Fab light chain 9606
315 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
316 5UEA 1 A, H Fab Heavy Chain 9606
317 5UEA 3 B, L Fab Light Chain 9606
318 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
319 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
320 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
321 3G5Y 1 A 175 light chain 10090
322 3G5Y 2 B 175 heavy chain 10090
323 5O02 2 C Nanobody (VHH) Nano-4 30538
324 5NMV 1 L Fab light chain 10088
325 5NMV 2 H Fab heavy chain 10088
326 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
327 4N8C 2 L, M Light chain of monoclonal antibody 10090
328 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
329 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
330 4HGW 1 A Antibody Fab fragment, light chain 10090
331 4HGW 2 B Antibody Fab fragment, heavy chain 10090
332 1NLB 1 L antibody 19D9D6 light chain 10090
333 1NLB 2 H antibody 19D9D6 heavy chain 10090
334 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
335 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
336 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
337 3VFG 1 L 3F8 Light Chain 10090
338 3VFG 2 H 3F8 Heavy Chain 10090
339 4X7F 2 C, D Nano-25 Nanobody 30538
340 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
341 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
342 3QRG 1 L Fab light chain 9606
343 3QRG 2 H Fab heavy chain Fd fragment 9606
344 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
345 5M6A 1 A, B, C, D Bence-Jones light chain 9606
346 4LLY 2 B, D light chain Clambda 9606
347 4LGR 2 B Camelid nanobody (VHH3) 30538
348 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
349 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
350 5EZI 1 H Fab c12 heavy chain 9606
351 5EZI 2 L Fab c12 Light chain 9606
352 4K23 1 H anti-uPAR antibody, heavy chain 10090
353 4K23 2 L anti-uPAR antibody, light chain 10090
354 5J57 2 B VHH single chain antibody V5E1 30538
355 3NCJ 1 L Fab15 Mut8 light chain 9606
356 3NCJ 2 H Fab15 Mut8 heavy chain 9606
357 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
358 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
359 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
360 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
361 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
362 5W05 1 L M59 FAB LIGHT CHAIN 10090
363 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
364 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
365 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
366 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
367 5OMM 2 C Nanobody (VHH) Nano-14 30538
368 5E03 1 A mouse CTLA-4 nanobody 10090
369 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
370 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
371 4M61 1 A, C Fab A52 light chain 10090
372 4M61 2 B, D Fab A52 heavy chain 10090
373 5YE3 1 B 2A7D9 VH CH1 chain 10090
374 5YE3 2 A 2A7D9 L chain 10090
375 5LZ0 1 A, B PorM nanobody 9844
376 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
377 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
378 1UM5 1 L Antibody 21H3 L chain 10090
379 1UM5 2 H Antibody 21H3 H chain 10090
380 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
381 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
382 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
383 4NWT 1 L APE1531 Ab Fab light chain 9606
384 4NWT 2 H APE1531 Ab Fab heavy chain 9606
385 6DBE 1 A, B nanobody VHH R303 9844
386 3WHX 1 A mAb Fab H fragment 10090
387 3WHX 2 B mAb Fab L fragment 10090
388 3NA9 1 L Fab15 light chain 9606
389 3NA9 2 H Fab15 heavy chain 9606
390 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
391 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
392 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
393 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
394 4LRI 1 A, B MSL-109 Light Chain 9606
395 4LRI 2 C, P MSL-109 Heavy Chain 9606
396 2XXC 1 B CAMELID VHH 9 30538
397 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
398 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
399 4JN2 1 A, L anti dabigatran Fab 10090
400 4JN2 2 B, H anti dabigatran Fab 10090
401 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
402 4XBE 2 H 4E10 Fab heavy chain 9606
403 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
404 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
405 6BE2 1 H Fab (F598) Heavy Chain 9606
406 6BE2 2 L Fab (F598) Light Chain 9606
407 3QYC 1 A, B VH domain of IgG molecule 9606
408 4JFZ 1 L Fab light chain 9606
409 4JFZ 2 H Fab heavy chain 9606
410 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
411 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
412 5VAK 2 B Nb914 Nanobody 9844
413 3WIF 1 A mAb Fab H fragment 10090
414 3WIF 2 B mAb Fab L fragment 10090
415 5U6A 1 A Light Chain 9606
416 5U6A 2 B Heavy Chain 9606
417 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
418 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
419 3MBX 1 L X836 LIGHT CHAIN 10090
420 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
421 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
422 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
423 2XXM 2 B CAMELID VHH 9 30538
424 6APC 1 H Epididymis luminal protein 214 9606
425 6APC 2 L IGL@ protein 9606
426 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
427 4HHA 1 A Fab KE5 Fab fragment KE5 9606
428 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
429 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
430 4RGO 2 H 14G8 heavy chain Fab 10090
431 4RGO 3 L 14G8 light chain Fab 10090
432 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
433 5GRY 1 A, G diabody 9606
434 5UEK 2 H Fab 12E Heavy Chain 9606
435 5UEK 3 L Fab 12E Light Chain 9606
436 3NAA 1 L Fab15 Mut5 light chain 9606
437 3NAA 2 H Fab15 Mut5 heavy chain 9606
438 6DBD 1 A, B, C, D nanobody VHH R326 9844
439 1Q0X 1 L Fab 9B1, light chain 10090
440 1Q0X 2 H Fab 9B1, heavy chain 10090
441 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
442 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
443 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
444 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
445 5JDS 1 B Nanobody 9835
446 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
447 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
448 5IK3 2 B, D 1E03 Fab fragment light chain 9606
449 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
450 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
451 5XLI 1 a, b FabL 10090
452 5XLI 2 c, d FabH 10090
453 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
454 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
455 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
456 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
457 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
458 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
459 4WUK 1 H CH65 heavy chain 9606
460 4WUK 2 L CH65 light chain 9606
461 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
462 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
463 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
464 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
465 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
466 5JOP 1 D, L Fab 14.22 light chain 10090
467 5JOP 2 E, H Fab14.22 heavy chain 10090
468 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
469 4HPO 1 H CH58 Fab heavy chain 9606
470 4HPO 2 L CH58 Fab light chain 9606
471 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
472 5UKN 2 L DH522UCA Fab fragment light chain 9544
473 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
474 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
475 5L21 2 B VHH-C2 30538
476 5IT2 1 H heavy chain 9606
477 5IT2 2 L light chain 9606
478 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
479 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
480 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
481 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
482 5FWO 1 A NANOBODY 9844
483 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
484 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
485 5MO3 3 L Fab of monoclonal antibody, light chain 10090
486 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
487 5GZ0 1 A, C FM329 light chain 1383439
488 5GZ0 2 B, D FM329 heavy chain 1383439
489 6DW2 1 A 6078 Fab light chain 9606
490 6DW2 2 B 6078 Fab heavy chain 9606
491 3B9V 1 A, B, C, D heavy chain variable domain 9606
492 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
493 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
494 6BQB 1 L MGG4 Fab light chain 9606
495 6BQB 2 H MGG4 Fab heavy chain 9606
496 4PUB 1 H DX-2930 HEAVY CHAIN 9606
497 4PUB 2 L DX-2930 LIGHT CHAIN 9606
498 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
499 6B14 2 L Light chain of Fab BL3-6S97N 10090
500 5N88 1 A, H VH59 antibody 9606
501 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
502 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
503 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
504 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
505 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
506 5GS3 1 A, H diabody protein 9606
507 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
508 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
509 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
510 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
511 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
512 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
513 5VKD 2 H Fab Heavy Chain 9606
514 5VKD 3 L Fab light chain 9606
515 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
516 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
517 5XHG 1 A, C polypeptide(L) 10090
518 5XHG 2 B, D polypeptide(H) 10090
519 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
520 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
521 3UYR 1 H antibody Fab heavy chain 10090
522 3UYR 2 L antibody Fab light chain 10090
523 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
524 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
525 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
526 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
527 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
528 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
529 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
530 3OAZ 2 K, L Fab 2G12, light chain 9606
531 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
532 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
533 1ZAN 1 L Fab AD11 Light Chain 10116
534 1ZAN 2 H Fab AD11 Heavy Chain 10116
535 6CJK 1 A, C Immunoglobulin Fab light chain 9986
536 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
537 4N0Y 1 H IGH526 Heavy Chain 9606
538 4N0Y 2 L IGH526 Light Chain 9606
539 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
540 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
541 5MTH 1 A, H antibody Fab heavy chain 10090
542 5MTH 2 B, L antibody Fab light chain 10090
543 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
544 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
545 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
546 1RZF 1 L Fab E51 light chain 9606
547 1RZF 2 H Fab E51 heavy chain 9606
548 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
549 4KTE 2 L GE148 Light Chain Fab 9544
550 5I8O 1 H HMM5 antibody heavy chain 9606
551 5I8O 2 L HMM5 antibody light chain 9606
552 4OUO 1 A anti Bla g 1 scFv 9031
553 4JG0 1 L Fab light chain 9606
554 4JG0 2 H Fab heavy chain 9606
555 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
556 4YGV 2 B, L aDabi-Fab2a light chain 9606
557 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
558 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
559 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
560 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
561 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
562 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
563 3EO0 1 A, C GC-1008 Fab Light Chain 10090
564 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
565 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
566 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
567 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
568 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
569 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
570 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
571 4POU 2 B VHH Antibody 9844
572 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
573 4FQI 3 H antibody CR9114 heavy chain Fab 9606
574 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
575 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
576 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
577 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
578 4JHA 2 L D25 light chain 9606
579 6B9Z 1 A Trastuzumab Fab light chain 10090
580 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
581 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
582 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
583 4PTT 1 A Antibody pn132p2C05, light chain 9606
584 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
585 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
586 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
587 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
588 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
589 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
590 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
591 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
592 2P42 2 B, D ANTIBODY CAB-RN05 9838
593 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
594 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
595 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
596 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
597 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
598 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
599 4DGV 1 H HCV1 Heavy Chain Fab 9606
600 4DGV 2 L HCV1 Light Chain 9606
601 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
602 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
603 5TH2 1 A, C cetuximab Fab, light chain 10090
604 5TH2 2 B, D cetuximab Fab, heavy chain 10090
605 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
606 5I8K 1 L HHH1 Fab Light chain 9606
607 5I8K 2 H HHH1 Fab Heavy chain 9606
608 4QLR 1 A, B Llama nanobody n02 VH domain 9844
609 5J56 2 B VHH single chain antibody V1C7 30538
610 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
611 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
612 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
613 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
614 1YNL 1 L Ig gamma light chain 10090
615 1YNL 2 H Ig gamma heavy chain 10090
616 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
617 5EPM 2 B, F Antibody Fab fragment light chain 10090
618 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
619 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
620 3UMT 1 A scFv heavy chain and light chain 10090
621 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
622 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
623 4NUJ 1 A PGT152 light chain 9606
624 4NUJ 2 B PGT152 heavy chain 9606
625 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
626 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
627 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
628 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
629 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
630 3U2S 2 B, L PG9 light chain 9606
631 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
632 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
633 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
634 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
635 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
636 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
637 4NUG 1 L PGT151 light chain 9606
638 4NUG 2 H PGT151 heavy chain 9606
639 3IU4 1 H chP3 Fab heavy chain 10090
640 3IU4 2 L chP3 Fab light chain 10090
641 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
642 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
643 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
644 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
645 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
646 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
647 1P7K 1 A, L antibody light chain FAB 10090
648 1P7K 2 B, H antibody heavy chain FAB 10090
649 4NBX 2 B A20.1 VHH 9844
650 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
651 3RVV 2 C 4C1 - light chain 10090
652 3RVV 3 D 4C1 - heavy chain 10090
653 4HEP 2 G vHH17 domain 9844
654 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
655 3P0Y 2 H Fab DL11 heavy chain 9606
656 3P0Y 3 L Fab DL11 light chain 9606
657 4NPY 1 A, L germline PGT121 light chain Fab 9606
658 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
659 6ANA 2 H LL2 Fab Heavy Chain 10090
660 6ANA 3 L LL2 Fab Light Chain 10090
661 5IBU 1 B, L 6652 Light Chain 9606
662 5IBU 2 G, H 6652 Heavy Chain 9606
663 5VPL 2 C 4C1 - LIGHT CHAIN 10090
664 5VPL 3 D 4C1 - HEAVY CHAIN 10090
665 6AOD 1 A FXIa Antibody FAB Light Chain 9606
666 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
667 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
668 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
669 2YPV 2 H FAB 12C1 10090
670 2YPV 3 L FAB 12C1 10090
671 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
672 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
673 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
674 4JY5 1 L PGT122 light chain Fab 9606
675 4JY5 2 H PGT122 heavy chain Fab 9606
676 6ELE 1 A, H fAB heavy chain 9606
677 6ELE 2 B, L fAB light chain 9606
678 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
679 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
680 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
681 6B5R 1 H CIS42 Fab Heavy chain 9606
682 6B5R 2 L CIS42 Fab Light chain 9606
683 5IML 2 B Nanobody 9835
684 3NAC 1 L Fab15 Mut7 light chain 9606
685 3NAC 2 H Fab15 Mut7 heavy chain 9606
686 3A6C 2 H IG VH, anti-lysozyme 10090
687 2DQD 2 H Ig VH,anti-lysozyme 10090
688 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
689 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
690 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
691 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
692 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
693 1Q72 1 L Fab M82G2, Light chain 10090
694 1Q72 2 H Fab M82G2, Heavy chain 10090
695 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
696 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
697 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
698 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
699 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
700 4YHO 1 H aDabi-Fab3 heavy chain 9606
701 4YHO 2 L aDabi-Fab3 light chain 9606
702 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
703 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
704 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
705 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
706 4DGY 1 H HCV1 Heavy Chain Fab 9606
707 4DGY 2 L HCV1 Light Chain 9606
708 3A67 2 H IG VH, anti-lysozyme 10090
709 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
710 5EN2 1 A GD01 heavy chain 10090
711 5EN2 2 B GD01 light chain 10090
712 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
713 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
714 1J1X 2 H Ig VH,anti-lysozyme 10090
715 5M2J 2 D Anti-(ED-B) scFV 9606
716 3MXW 2 L 5E1 light chain 9606
717 3MXW 3 H 5E1 heavy chain 9606
718 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
719 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
720 2DQC 2 H Ig VH,anti-lysozyme 10090
721 1J1O 2 H Ig VH,anti-lysozyme 10090
722 3EO9 1 L Efalizumab Fab fragment, light chain 9606
723 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
724 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
725 4M62 2 H, I GEP2 FV heavy chain 9606
726 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
727 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
728 5IVO 1 A BC2-nanobody 30538
729 1J1P 2 H Ig VH,anti-lysozyme 10090
730 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
731 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
732 4NBZ 2 B, D A26.8 VHH 9844
733 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
734 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
735 5WUV 1 L light chain 9606
736 5WUV 2 H heavy chain 9606
737 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
738 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
739 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
740 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
741 5AYU 2 H Ig VH,anti-lysozyme 10090
742 4JM4 1 H PGT 135 Heavy Chain Fab 9606
743 4JM4 2 L PGT 135 Light Chain Fab 9606
744 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
745 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
746 3A6B 2 H IG VH, anti-lysozyme 10090
747 2DQJ 2 H Ig VH,anti-lysozyme 10090
748 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
749 5YE4 2 B, D 1A9D7 L chain 10090
750 5F21 2 B nanobody MU375 9844
751 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
752 6B0G 1 C 1245 Antibody, Light Chain 9606
753 6B0G 2 D 1245 Antibody, Heavy Chain 9606
754 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
755 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
756 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
757 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
758 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
759 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
760 6D0X 1 A 2140 Antibody, heavy chain 9606
761 6D0X 2 B 1210 Antibody, light chain 9606
762 2P44 2 B ANTIBODY CAB-RN05 9838
763 6BE4 1 H Fab (F598) Heavy Chain 9606
764 6BE4 2 L Fab(F598) Light Chain 9606
765 5TPP 1 L DH270.5 Fab heavy chain 9606
766 5TPP 2 H DH270.5 Fab light chain 9606
767 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
768 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
769 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
770 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
771 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
772 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
773 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
774 5TP3 1 A, B F-VHH-4 9844
775 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
776 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
777 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
778 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
779 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
780 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
781 5TL5 1 L M2177 LIGHT CHAIN 10090
782 5TL5 2 H M2177 HEAVY CHAIN 10090
783 2FX7 1 L Fab 4E10 Light Chain 9606
784 2FX7 2 H Fab 4E10 Heavy Chain 9606
785 5Y9K 1 L belimumab light chain 9606
786 5Y9K 2 H belimumab heavy chain 9606
787 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
788 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
789 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
790 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
791 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
792 4LHJ 2 B Camelid antibody 30538
793 3WFH 1 A mAb Fab H fragment 10090
794 3WFH 2 B mAb Fab L fragment 10090
795 4BEL 2 D, E XA4813 9844
796 5M7Q 1 A, B Nanobody NbD2 9838
797 5H8D 1 A VHH nanobody 9844
798 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
799 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
800 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
801 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
802 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
803 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
804 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
805 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
806 3DUR 2 B, D Ig-like protein 10090
807 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
808 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
809 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
810 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
811 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
812 5HI4 3 D, L CAT-2000 FAB light chain 9606
813 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
814 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
815 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
816 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
817 3RVW 2 C 4C1 - light chain 10090
818 3RVW 3 D 4C1 - heavy chain 10090
819 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
820 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
821 5XKU 2 B HNIgGA6 light chain 9606
822 5XKU 3 C HNIgGA6 heavy chain 9606
823 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
824 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
825 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
826 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
827 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
828 5HI5 3 D, L CAT-2000 light chain 9606
829 5JO5 1 A, C, E, H 10E8 gHV 9606
830 5JO5 2 B, D, F, L 10E8 gLV 9606
831 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
832 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
833 2XV6 2 B, D CAMELID VHH 9 30538
834 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
835 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
836 5CCK 2 L Antibody 3BC315 Fab light chain 9606
837 5VM0 1 A, B Camelid Nanobody VHH T9 9844
838 5I76 1 A, C FM318_light_chain 1383439
839 5I76 2 B, D FM318_heavy_cahin 1383439
840 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
841 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
842 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
843 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
844 5I18 1 L FAB LIGHT CHAIN 9606
845 5I18 2 H FAB HEAVY CHAIN 9606
846 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
847 4JN1 2 L anti-dabigatran Fab1, light chain 10090
848 4ZG1 1 A, B, C, D, E, F NB17 9844
849 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
850 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
851 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
852 4G5Z 2 L canakinumab antibody fragment light chain 9606
853 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
854 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
855 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
856 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
857 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
858 2OK0 2 L Fab ED10 light chain 10090
859 2OK0 3 H Fab ED10 heavy chain 10090
860 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
861 3SOB 1 L antibody light chain 9606
862 3SOB 3 H antibody heavy chain 9606
863 6B5M 1 H CIS43 Fab Heavy chain 9606
864 6B5M 2 L CIS43 Fab Light chain 9606
865 4I1N 2 B Protein ca1697 (nanobody) 9844
866 5AWN 1 H Heavy chain of 3BC176 Fab 9606
867 5AWN 2 L Light chain of 3BC176 Fab 9606
868 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
869 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
870 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
871 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
872 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
873 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
874 5DR5 2 L AbD09097 Fab light chain 9606
875 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
876 2IH3 1 A FAB Heavy Chain 10090
877 2IH3 2 B FAB Light Chain 10090
878 4KQ3 1 L CNTO3186 light chain Fab 9606
879 4KQ3 2 H CNTO3186 heavy chain Fab 9606
880 6F0D 1 A, B VHH antibody BCD090-M2 9844
881 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
882 6AQ7 3 L POM6 FAB light CHAIN 10090
883 4JFX 1 A, L Fab light chain 9606
884 4JFX 2 B, H Fab heavy chain 9606
885 3SGE 1 I, L Light Chain 10090
886 3SGE 2 H, J Heavy Chain 10090
887 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
888 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
889 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
890 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
891 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
892 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
893 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
894 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
895 5FHB 1 H Antibody 100 Fab heavy chain 9606
896 5FHB 2 L Antibody 100 Fab light chain 9606
897 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
898 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
899 1JGU 1 L Antibody Light Chain 10090
900 1JGU 2 H Antibody Heavy Chain 10090
901 4I77 1 H Lebrikizumab heavy chain Fab 9606
902 4I77 2 L Lebrikizumab light chain Fab 9606
903 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
904 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
905 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
906 4O4Y 2 H 2095-2 heavy chain 9986
907 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
908 5OBF 1 H fAb Heavy chain 10090
909 5OBF 2 L fAb Light chain 10090
910 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
911 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
912 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
913 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
914 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
915 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
916 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
917 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
918 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
919 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
920 5MHE 1 L Fab-fragment 10090
921 5MHE 2 H Fab-fragment 10090
922 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
923 4GLR 3 I, K anti-ptau light chain light chain 9031
924 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
925 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
926 4HJG 1 A Trastuzumab light chain 9606
927 4HJG 2 B Trastuzumab heavy chain 9606
928 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
929 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
930 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
931 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
932 5I30 1 L Fab PL-2 light chain 10090
933 5I30 2 H Fab PL-2 heavy chain 10090
934 4W6X 2 B Nanobody NbFedF7 9844
935 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
936 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
937 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
938 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
939 3FN0 1 L Fab Z13e1 light chain 9606
940 3FN0 2 H Fab Z13e1 heavy chain 9606
941 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
942 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
943 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
944 4YHI 2 B, L aDabi-Fab2a light chain 9606
945 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
946 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
947 4OSU 1 H SM5-1 Fab Heavy Chain 9606
948 4OSU 2 L SM5-1 Fab Light Chain 9606
949